SITC 2022 ANNUAL  MEETING

EpiVaxTx_SITC22_Melanoma_17Nov22_56Wx31.5H.png

TUMOR HOMOLOGY WITH SELF AS A BIOMARKER FOR RESPONSE TO CHECKPOINT INHIBITOR THERAPY

Guilhem Richard, Ph.D.

2022 SITC Annual Meeting

November 2022